Accuracy of tissue polypeptide specific antigen (TPS) in the diagnosis of ovarian malignancy

Anticancer Research

Volumn 20, Issue 2 B, 2000, Pages 1291-1295

  Padungsutt, P ^a   Thirapagawong, C ^a   Senapad, S ^a   Suphanit, I ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Ovarian malignancy; Tumor marker TPS

Indexed keywords

TISSUE POLYPEPTIDE ANTIGEN;

ACCURACY; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; OVARY CANCER; OVARY TUMOR; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC;

ADOLESCENT; ADULT; AGED; CARCINOMA; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GERMINOMA; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PELVIC NEOPLASMS; PEPTIDES; PHYSICAL EXAMINATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THECOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 0034055640     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Shabana A, Onsrud M: Tissue Polypeptide Specific Antigen and CA 125 as serum tumor markers in ovarian carcinoma. Tumor Biol 15: 361-367, 1994.
2. Inoue M, Fujita M, Nakazawa A, Ogawa H, Tanizawa O. Sialyl-Tn, Sialyl-Lewis Xi, CA 125, CA 19-9, CEA, and Tissue Polypeptide Antigen in differentiating ovarian cancer from benign tumors. Obstet Gynecol 79: 434-440, 1992.
3. Salman T, El-Ahmady O, Sawsan MR, Nahed MH: The clinical value of serum TPS in gynecological malignancies. Int J Biol Markers 10: 81-86, 1995.
4. Bjorklund B: On the nature and clinical use of Tissue Polypeptide Antigen (TPA). Tumor Diagnostik I: 9-20, 1980.
5. Gion M, Mione R, Becciolini A, Balzi M, Correale M, Piffanelli A, Giovannini G, Saccani Jotti G, Fontanesi M: Relationship between cytosol TPS, TPA and cell proliferation. Int J Biol Markers 9: 109-114, 1944.
6. Bonfrer JM, Groeneveld EM, Korse CM, Van Dalen A, Oomen LC, Ivanyi D: Monoclonal antibody M3 used in Tissue Polypeptide Specific Antigen assay for quantification of Tissue Polypeptide Antigen recognizes keratin 18. Tumor Biol 15: 210-222, 1994.
7. van Dalen A, Heering KJ, Barak V, Peretz T, Cremaschi A, Geroni P, Gion M, Saracchini S, Molina R, Namer M, Stieber P, Sturgeon C, Leonard RCF, Einarsson R: Treatment response in metastatic breast cancer. A multicentre study comparing UICC criteria and tumour marker changes. The Breast 5: 82-88, 1996.
8. Bjorklund B, Einarsson R: TPS (Tissue Polypeptide Specific Antigen) in Oncologic Practice: a Review with Reference to 3000 Cases of Breast Cancer. Tumordiagn u Ther 17: 67-73, 1996.
9. Einarsson R: Comment letter: TPS in lung cancer. Pandora 10: 35-36, 1998.
10. Inoue M, Inoue Y, Hiramatsu K, Ueda G: The clinical value of tissue polypeptide antigen in patient with gynecological tumors. Cancer 55: 2618-2623, 1985.
11. Hamase A, Kawanaka M, Kitani H, Fukuchi M: Evaluation of BEKI TPS radioassay kit as a one step immunoradiometric assay utilizes monoclonal and polyclonal antibodies specific for serum Tissue Polypeptide Antigen. Jap J Nucl Med 31: 995-1003, 1994.
12. Sliutz G, Tempfer C, Kainz C, Mustafa G, Gitsch G, Koelbl H, Biegelmayer Ch: Tissue polypeptide Specific Antigen and cancer associated serum antigen in the follow up of ovarian cancer. Anticancer Res 15: 1127-1130, 1995.